01419.HK
Human Health Holdings Limited
HKSE · Healthcare · Medical - Care Facilities · HK
HKD 0.77
+0.66%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.3B | 644.4M | 590.8M | 1.0B | 1.1B |
| Cost of Revenue | 728.6M | 347.9M | 321.0M | 408.5M | 462.1M |
| Gross Profit | 553.9M | 296.6M | 269.9M | 593.2M | 659.7M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 394.4M | 197.5M | 183.7M | 211.4M | 167.8M |
| General & Admin Expense | 354.1M | 197.7M | 184.5M | 211.2M | 166.7M |
| Selling & Marketing Expense | (61.9M) | (233.0K) | (773.0K) | 189.0K | 1.1M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 394.4M | 197.5M | 183.7M | 211.4M | 167.8M |
| Cost and Expenses | 1.1B | 545.3M | 503.1M | 694.9M | 693.0M |
| Operating Income (EBIT) | 159.5M | 99.1M | 17.9M | 307.1M | 428.8M |
| Non-Operating | |||||
| Interest Income | 24.7M | 12.7M | 17.2M | 8.5M | 199.0K |
| Interest Expense | 13.8M | 6.5M | 8.2M | 8.3M | 2.9M |
| Net Interest Income | 10.9M | 6.2M | 8.9M | 194.0K | (2.7M) |
| Other Non-Op Income/Expense | (55.2M) | (69.2M) | (61.2M) | (68.1M) | 16.4M |
| Non-Operating Income (excl Interest) | 96.8M | 67.7M | (17.9M) | 58.4M | (27.8M) |
| EBT (Pre-Tax Income) | 55.4M | 29.9M | 26.6M | 238.8M | 445.3M |
| Income Tax Expense | 5.5M | 3.3M | 2.4M | 58.0M | 70.0M |
| Bottom Line | |||||
| Net Income | 48.7M | 26.3M | 24.2M | 180.8M | 375.3M |
| Earnings from Cont. Ops | 49.7M | 26.6M | 24.2M | 180.8M | 375.3M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 48.7M | 26.3M | 24.2M | 180.8M | 375.3M |
| Per Share | |||||
| Basic EPS | HK$0.13 | HK$0.07 | HK$0.06 | HK$0.48 | HK$0.99 |
| Diluted EPS | HK$0.13 | HK$0.07 | HK$0.06 | HK$0.48 | HK$0.99 |
| Revenue Per Share | HK$3.38 | HK$1.70 | HK$1.56 | HK$2.64 | HK$2.96 |
| Shares | |||||
| Basic Shares Outstanding | 379.6M | 379.6M | 379.6M | 379.6M | 379.6M |
| Diluted Shares Outstanding | 379.6M | 379.6M | 379.6M | 379.6M | 379.6M |
| Profitability Metrics | |||||
| EBITDA | 198.5M | 52.3M | 104.1M | 323.5M | 513.2M |
| D&A | 135.8M | 20.9M | 68.0M | 75.0M | 63.1M |
| EBIT | 62.7M | 31.4M | 35.9M | 248.5M | 448.2M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Dec 1, 2025